Overview & Mechanism
Binds the GHS (ghrelin) receptor, triggering robust GH release from the pituitary; more potent than GHRP-6 with less hunger effect.
Research Dosage
100–300 mcg per dose
Subcutaneous injection
2–3 times daily
4–8 weeks
Reconstitution & Storage
Reconstitute a 5 mg vial with 2 mL of bacteriostatic water (2.5 mg/mL).
Lyophilized: −20 °C. Reconstituted: refrigerate 2–8 °C, use within 28–30 days.
Safety & Side Effects
May increase appetite and cause mild cortisol/prolactin elevation. Avoid food around dosing.
Studies
GHRP-2 GH release in healthy men
GHRP-2 produced a dose-dependent GH release significantly greater than placebo in healthy male volunteers.
Read studyReferences
Research Use Only
This information is intended for licensed researchers and educational purposes only. It does not constitute medical advice. PureLife Health products are not approved for human use by Health Canada or the FDA. Always consult a qualified medical professional and verify against current literature.